Replies to post #535386 on NorthWest Biotherapeutics Inc (NWBO)

[Bright Boy]

A partnership really does make the most sense, Gary. That way, everybody wins and everybody is allowed to participate in the future of immunotherapy. Northwest and its shareholders receive the benefit of ever increasing share price coupled with the financial strength of the BP partner, shareholders can treat their holdings as a bank account with ever appreciating values and are able to increase their assets free of taxation until they sell.

Patients will have access to their treatments on a much faster and broader scale and will be availed of ever increasing and improving immunotherapy technologies aided by the sheer numbers of experts that will be tasked with that job.

BP partners will be encouraged to share technologies providing economies of scale never before seen in the battles to defeat cancers!!!

A partnership provides what has always been required to win the war against cancer and that is that everyone involved will be respected for their contributing capabilities and importance to the process and will be a part of rather than apart from !!!

It truly is a "Win Win" deal !!

Cheers,

BB

[hump4]

The reason Linda waited this long was to get her ducks in a row. It's been a long three years to get these results out. BP has tried for 10 years to destroy the company. Linda knows she has one shot at getting this right. I speculate there will be mores news drops to destroy the shorts and once we get momentum there will be a massive short squeeze. She has discussed this illegal shorting strategy in prior shareholder meetings. Yes, you are right that $40 is cheap if DCVax works on all solid tumors. That would make it the holy grail of cancer treatments. That's why I said $300 is possible and that horse's ass mocked it. I'm not sure if she can go it alone but she can partner , which might be a part of the news strategy.

[biosectinvestor]

I don’t doubt that they will look for ways to expedite access to the drug and to new and relevant combinations through partnership deals. I think their biggest challenge will likely be avoiding one-off big partnerships and doing multiple development deals including with partners competing with each other. It will be tempting to take the first big deal offered, but that may not be the best deal in the long-run.

[churchill_21]

Agreed Gary. A BO or partnership most certainly is on the table, as the chance of NWBO commercializing the treatment, at least on their own, is next to zero. To your point, timing is key here, I think there needs to be additional de-risking in the form of approval from the FDA specifically, at least for the BO. MHRA approval is great, but does not guarantee an FDA approval, and that's really what matters. Like you said, there could be plans right now though, to partner with big pharma in getting this through approval process with a BO after approval. My 2 cents based on launching drugs for big pharma.